AGL Produkte
(Amylo-alpha-1, 6-Glucosidase, 4-alpha-Glucanotransferase (AGL))
Kategorien
This gene encodes the glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in this gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008].
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte AGL Kategorien
AGL Antikörper
High quality antibodies with extensive validation data.
AGL ELISA Kits
Reliable ELISA kits for a wide range of species.
AGL Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene AGL Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Applikation
WB, IF
Validierungen
- (6)
- (4)
Kat. Nr.
ABIN389030
Menge
400 μL
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
WB, IF
Validierungen
- (10)
- (2)
Kat. Nr.
ABIN1882062
Menge
400 μL
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
WB, IF
Validierungen
- (2)
Kat. Nr.
ABIN6243594
Menge
400 μL
Datenblatt
Datenblatt
Empfohlene AGL ELISA Kits
Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (1)
Kat. Nr.
ABIN6953680
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Human
Analytical Method
Sandwich ELISA
Validierungen
Kat. Nr.
ABIN418882
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Dog
Analytical Method
Validierungen
Kat. Nr.
ABIN2870202
Menge
96 tests
Datenblatt
Datenblatt
Empfohlene AGL Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Mouse
Source
Escherichia coli (E. coli)
Validierungen
Kat. Nr.
ABIN7422415
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Human
Source
Escherichia coli (E. coli)
Validierungen
Kat. Nr.
ABIN7420006
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Human
Source
HEK-293 Cells
Validierungen
- (1)
Kat. Nr.
ABIN2714454
Menge
20 μg
Datenblatt
Datenblatt
Neueste Publikationen zu unseren AGL Produkten
: "Commentary on: "Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study." Tombal B, Borre M, Rathenborg P, Werbrouck P, Van Poppel H, ..." in: Urologic oncology, (2015) (PubMed).: "Muscle glycogen remodeling and glycogen phosphate metabolism following exhaustive exercise of wild type and laforin knockout mice." in: The Journal of biological chemistry, (2015) (PubMed).
: "Loss of glycogen debranching enzyme AGL drives bladder tumor growth via induction of hyaluronic acid synthesis." in: Clinical cancer research : an official journal of the American Association for Cancer Research, (2015) (PubMed).
: "Laforin-malin complex degrades polyglucosan bodies in concert with glycogen debranching enzyme and brain isoform glycogen phosphorylase." in: Molecular neurobiology, Vol. 49, Issue 2, pp. 645-57, (2014) (PubMed).
: "Anti-retinal antibodies in patients with macular telangiectasia type 2." in: Investigative ophthalmology & visual science, Vol. 54, Issue 8, pp. 5675-83, (2013) (PubMed).
: "Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin." in: The Journal of biological chemistry, Vol. 285, Issue 33, pp. 25372-81, (2010) (PubMed).
: "Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis." in: Muscle & nerve, Vol. 39, Issue 6, pp. 739-53, (2009) (PubMed).
: "Abnormal metabolism of glycogen phosphate as a cause for Lafora disease." in: The Journal of biological chemistry, Vol. 283, Issue 49, pp. 33816-25, (2008) (PubMed).
: "A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease." in: Genes & development, Vol. 21, Issue 19, pp. 2399-409, (2007) (PubMed).
: "Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III." in: Journal of human genetics, Vol. 47, Issue 2, pp. 55-9, (2002) (PubMed).
Synonyme und alternative Namen zu AGL
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase (AGL), glycogen debranching enzyme (agl), glycogen debranching protein (MMAH_RS03870), amylo-1,6-glucosidase, 4-alpha-glucanotransferase (Agl), amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase (Agl), 1110061O17Rik, 9430004C13Rik, 9630046L06Rik, AI850929, C77197, DDBDRAFT_0219237, DDBDRAFT_0234114, DDB_0219237, DDB_0234114, GDEBezeichner auf Proteinebene für AGL
- amylo-1, 6-glucosidase, 4-alpha-glucanotransferase (glycogen debranching enzyme, glycogen storage disease type III)
- glycogen debranching enzyme
- amylo-1, 6-glucosidase, 4-alpha-glucanotransferase
- amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
- glycogen storage disease type III
- glycogen debrancher
- amylo-1,6-glucosidase, 4-alpha-glucanotransferase
- Glycogen debrancher
Sie sind hier:
